Charles River Laboratories Intl. Inc vs Roundhill S&P 500 0DTE Covered Call Strategy ETF — how do they compare? Charles River Laboratories Intl. Inc trades at $282.01 (market cap $13.46B), while Roundhill S&P 500 0DTE Covered Call Strategy ETF trades at $39.51. The key difference: Charles River Laboratories Intl. Inc is trading nearer its 52-week high, Roundhill S&P 500 0DTE Covered Call Strategy ETF nearer its low. Which is the better fit depends on your goals.
| CRL | XDTE | |
|---|---|---|
Market Cap | $13.46B | — |
Sector | Health | Income / Options Overlay |
52-Week High | $282.00 | $44.76 |
52-Week Low | $145.57 | $36.00 |
Enterprise Value | $16.30B | — |
Trailing returns across standard periods
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →XDTE is an actively managed ETF that utilizes a synthetic covered call strategy on the S&P 500 Index using zero-days-to-expiration (0DTE) options. It seeks to provide high weekly income and overnight exposure to the index while mitigating some volatility through daily option premium harvesting.
Read more on XDTE →